CGRP Migraine Therapies in 2025: Navigating New Safety Warnings for Raynaud’s Phenomenon and Hypertension
Update: 2025-09-25
Description
Drs. Hindiyeh and Hutchinson review new FDA-issued safety warnings for Raynaud's phenomenon and hypertension in CGRP-based migraine treatment. They explore the impact of this label update and share practical strategies for patient management.
Comments
In Channel